Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 3

1(20.0%)

5Total

N/A(4)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT02017171Phase 3Completed

A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes

Role: collaborator

NCT03274362Not ApplicableUnknown

Headspace Mindfulness App Trial

Role: lead

NCT03083795Not ApplicableUnknown

The Effect of Social Relationships on Psychological Distress and Disease Progression in Patients With Diabetes

Role: lead

NCT02019446Not ApplicableUnknown

Laser Treatment for Onychomycosis in Diabetes

Role: lead

NCT01659294Not ApplicableCompleted

Diabetes Outcomes and Nurse Case Manager Study

Role: lead

All 5 trials loaded